New T‑cell therapy targets three tumor proteins, shows early survival gains in aggressive pediatric brain cancers

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors, including diffuse intrinsic pontine glioma (DIPG) and relapsed central nervous system (CNS) tumors.

Read more: https://medicalxpress.com/news/2026-06-tcell-therapy-tumor-proteins-early.html